Advertisement

Topics

Cambridge Research Biochemicals to Support Preclinical Study on Treatment for Vision-Damaging Eye Disease

03:30 EDT 22 May 2018 | Sciad Newswire

Cleveland, UK, 22nd May 2018 / Sciad NewswireUnder a new contract, Cambridge Research Biochemicals® will support evaluation of a potential new treatment approach for Fuchs Dystrophy, a disease that typically occurs in middle age and may cause a gradual loss of vision.

Original Article: Cambridge Research Biochemicals to Support Preclinical Study on Treatment for Vision-Damaging Eye Disease

NEXT ARTICLE

More From BioPortfolio on "Cambridge Research Biochemicals to Support Preclinical Study on Treatment for Vision-Damaging Eye Disease"

Advertisement
Quick Search
Advertisement
Advertisement